Search

everythinglearnresearchcommunity

for

Search:↓

Oral and topical tranexamic acid effectively and safely improve melasma.

Manganese levels in hair may be linked to multiple sclerosis.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

A new MTX2 gene mutation caused a severe genetic disorder in a young Chinese girl.

The case shows how hard it is to tell apart Multiple Autoimmune Syndrome from other similar autoimmune conditions, but correct diagnosis is key for treatment to work.

The LMNA mutation affects skin structure even in asymptomatic carriers.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Malassezia folliculitis mainly affects the trunk in males and is better detected with d-PAS staining.

Early diagnosis and treatment of myositis in SLE patients lead to positive outcomes.

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

A patient with a rare disease had a unique genetic mutation linked to their symptoms.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

Msx2 deficiency in mice leads to bone growth and organ development problems.

Mesenchymal stem cell therapy shows promise for treating certain inflammatory skin diseases, but more research is needed.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Increasing isoleucine intake improved skin and health issues in an infant with maple syrup urine disease.

Certain proteins involved in DNA modification may affect the genetic changes in systemic lupus erythematosus and could indicate the disease's activity.

Timely and aggressive treatment is crucial for improving outcomes in severe complications of adult-onset Still's disease.

Most children with MIS-C showed significant improvement by 6 months.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

MRL/MpJ mice heal burns slower with more scarring and less tissue regeneration than BALB/c mice.

Removing MCPIP1 from myeloid cells in mice leads to hair loss and prevents skin tumors but causes pigmented spots.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

MicroRNAs could help assess and manage multiple chronic diseases.

A patient with a new PLEC gene mutation showed symptoms of both muscular dystrophy and myasthenia gravis, which improved with steroid treatment.

Polysulfonic acid mucopolysaccharide can reduce skin scarring.